Fig. 13
From: E2F transcription factors as multimodal biomarkers for pan-cancer management

Relationship between expression of E2F family genes and the clinicopathological features of bladder carcinoma and molecular typing. (A) Correlation of E2F expression and Clinicopathologic Characteristics in Bladder Urothelial Carcinoma. (B) Expression levels of the E2F family genes in the BLCA. The X-axis and Y-axis represent immune subtypes and E2F expression levels, respectively. C1, wound healing; C2, IFN-g dominant; C3, inflammatory; C4, lymphocyte depleted; C5, immunologically quiet; C6, TGF-b dominant. p < 0.05; **p < 0.01; ***p < 0.001.